AngioDynamics, Inc.

NasdaqGS:ANGO Stock Report

Market Cap: US$361.2m

AngioDynamics Dividends and Buybacks

Dividend criteria checks 0/6

AngioDynamics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

0.05%

Buyback Yield

Total Shareholder Yield0.05%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

There Is A Reason AngioDynamics, Inc.'s (NASDAQ:ANGO) Price Is Undemanding

Dec 10
There Is A Reason AngioDynamics, Inc.'s (NASDAQ:ANGO) Price Is Undemanding

AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Jul 19
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

Jul 18
Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

AngioDynamics: A Story To Monitor

May 14

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 09

AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

Apr 06
AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

AngioDynamics: Restructuring Initiative May Not Go Far Enough

Jan 14

AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 12
AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

Mar 31
AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance

Oct 06

AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold

Sep 29

Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

Sep 02
Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M

Jul 12

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ANGO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ANGO's dividend payments have been increasing.


Dividend Yield vs Market

AngioDynamics Dividend Yield vs Market
How does ANGO dividend yield compare to the market?
SegmentDividend Yield
Company (ANGO)n/a
Market Bottom 25% (US)1.4%
Market Top 25% (US)4.5%
Industry Average (Medical Equipment)1.7%
Analyst forecast (ANGO) (up to 3 years)n/a

Notable Dividend: Unable to evaluate ANGO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ANGO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ANGO's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ANGO has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:27
End of Day Share Price 2024/12/20 00:00
Earnings2024/08/31
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AngioDynamics, Inc. is covered by 17 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew TaylorBarclays
John YoungCanaccord Genuity
William PlovanicCanaccord Genuity